Jaguar Health (JAGX) Other Accumulated Expenses (2014 - 2026)
Jaguar Health's (JAGX) quarterly Other Accumulated Expenses came in at $262000.0 in Q1 2026, up 2083.33% on a QoQ basis from $12000.0 in Q4 2025.
Jaguar Health (JAGX) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Other Accumulated Expenses data on file, last reported at $262000.0 in Q1 2026.
- On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $262000.0 in Q1 2026; TTM through Mar 2026 was $262000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $12000.0, down 7.69% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $262000.0, up from $12000.0 in the prior quarter.
- Over the last five years, Other Accumulated Expenses for JAGX reached as high as $2.0 million in Q4 2023 and fell as low as $9000.0 in Q4 2022.
- Historically, Other Accumulated Expenses has averaged $462600.0 across 5 years, with a median of $13000.0 in 2024.
- Across the five-year window, Other Accumulated Expenses soared 22311.11% in 2023 and plunged 99.36% in 2024, its largest moves.
- Year by year, Other Accumulated Expenses stood at $9000.0 in 2022, then surged by 22311.11% to $2.0 million in 2023, then plunged by 99.36% to $13000.0 in 2024, then declined by 7.69% to $12000.0 in 2025, then surged by 2083.33% to $262000.0 in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $262000.0 in Q1 2026, $12000.0 in Q4 2025, and $13000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 262,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 2.02 Mn |
| Dec 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 285,000.00 |
| Dec 31, 2020 | 978,000.00 |
| Dec 31, 2019 | 827,000.00 |
| Dec 31, 2018 | 2.08 Mn |
| Mar 31, 2018 | 329,948.00 |
| Dec 31, 2017 | 533,882.00 |
| Sep 30, 2017 | 366,017.00 |
| Jun 30, 2017 | 156,040.00 |
| Mar 31, 2017 | 14,921.00 |
| Dec 31, 2016 | 45,714.00 |
| Sep 30, 2016 | 12,870.00 |
| Jun 30, 2016 | 19,479.00 |
| Mar 31, 2016 | 23,485.00 |
| Dec 31, 2015 | 82,266.00 |
| Sep 30, 2015 | 216,292.00 |